当前位置: 首页 > 期刊 > 《健康必读·下旬刊》 > 2019年第3期
编号:13320303
终末期糖尿病肾病血液透析患者阿司匹林抵抗现象分析(1)
http://www.100md.com 2019年3月1日 《健康必读·下旬刊》 2019年第3期
     【摘 要】目的:分析接受血液透析治疗的终末期糖尿病肾病患者中发生的阿司匹林抵抗现象。方法:选择2016年9月到2018年5月在我院接受血液透析治疗的糖尿病肾病71例为研究组,另选同期非血液透析的糖尿病肾病患者71例为对照组,两组均接受阿司匹林治疗后对比相关指标。结果:研究组中阿司匹林抵抗率及C反应蛋白水平显著高于对照组,P<0.05。结论:血液透析糖尿病肾病患者有更高风险发生阿司匹林抵抗,需加强监测。

    【关键词】终末期糖尿病肾病;血液透析;阿司匹林抵抗;预防措施

    Abstract Objective:to analyze aspirin resistance in patients with end-stage diabetic nephropathy treated with hemodialysis. Methods:from September 2016 to May 2018, 71 cases of diabetic nephropathy treated by hemodialysis in our hospital were selected as study group and 71 cases of non-hemodialysis patients as control group. The two groups were treated with aspirin to compare the relevant indicators. Results:the aspirin resistance rate and C-reactive protein level in the study group were significantly higher than those in the control group (P < 0.05). Conclusion:Hemodialysis diabetic nephropathy patients have a higher risk of aspirin resistance ......
1 2下一页

您现在查看是摘要页,全文长 4911 字符